(PharmaNewsWire.Com, March 15, 2018 ) APAC hemostats market is expected to reach USD 595.1 million by 2024, from USD 327.6 million in 2016 growing at a CAGR of 7.8% in the forecast period 2017 to 2024.
Based on geography, the APAC hemostats market is segmented into 10 geographical regions, such as: 1) Japan 2) China 3) South Korea 4) India 5) Australia 6) Singapore 7) Thailand 8) Malaysia 9) Indonesia 10) Philippines
APAC hemostats market competition by top players including: 1) Baxter 2) Vascular Solutions Inc. 3) B.Braun Melsungen 4) 3-D Matrix Ltd. 5) Resorba Medical GmbH 6) Anika Therapeutics Inc. 7) Arch Therapeutics Inc 8) Biom’Up SAS 9) CryoLife Inc. 10) Gamma Therapeutics Inc 11) Hemostasis LLC 12) MedTrade Products Limited 13) Stryker
The APAC hemostats market is segmented on the basis of type, application, distribution channel, and end user.
The APAC hemostats market is segmented into 5 major types, namely thrombin based hemostats, combination agents, oxidized regenerated cellulose based haemostats, gelatin based haemostats and collagen based haemostats.
On the basis of application, the market is segmented into surgery and wound closure.
On the basis of end users, the market is classified into hospitals, community healthcare, ambulatory centres and clinics.
About Us: Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
